Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

ABSTRACT:

Importance

People who have been infected with or vaccinated against SARS-CoV-2 have reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 antibodies from infection or vaccination is uncertain.

Objective

To estimate trends in SARS-CoV-2 seroprevalence related to infection and vaccination in the US population.

Design, setting, and participants

In a repeated cross-sectional study conducted each month during July 2020 through May 2021, 17 blood collection organizations with blood donations from all 50 US states; Washington, DC; and Puerto Rico were organized into 66 study-specific regions, representing a catchment of 74% of the US population. For each study region, specimens from a median of approximately 2000 blood donors were selec

SUBMITTER: Jones JM 

PROVIDER: S-EPMC8414359 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature